Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Scientific research
New research suggests that hypothalamic neurons use muropeptides as a measure of food intake or of imbalances in the gut microbiota.
Scientific research
New research suggests that the gut microbiota protects the femoral head through the production of extracellular vesicles.
Nutrition, Pediatrics
New research suggests that B. infantis can be used to treat children with acute malnutrition.
Nutrition
New research suggests that restoring the gut microbiota’s capacity to sense dietary signals mediated by specific host factors may improve metabolic problems.
Gastroenterology
The virome might be used in therapeutic approaches: eliminating or replacing disease-driving intestinal viruses with health-promoting viruses may be beneficial for people with IBD.
Endocrinology
Researchers found that models of conventional risk factors and data on the gut microbiota improved the prediction of liver diseases
Oncology
New research indicates that the tumor-resident microbiota can promote the formation of metastases as well as the survival of cancer cells during tumor progression.
Gastroenterology
By analyzing stool samples from dozens of people in Sweden, researchers have found that the microbiota isn’t stable in adulthood.
Cardiology, Gastroenterology
Researchers have identified 10 species whose abundance was linked to blood levels of TMAO, a metabolite associated with cardiovascular diseases
Scientific research
Researchers have found that cooperation among microbial cells may be one of causes of this drug tolerance.